Intervention Review

Zuclopenthixol dihydrochloride for schizophrenia

  1. Ajit Kumar1,*,
  2. Daniel Strech2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 OCT 2005

Assessed as up-to-date: 10 JUL 2005

DOI: 10.1002/14651858.CD005474

How to Cite

Kumar A, Strech D. Zuclopenthixol dihydrochloride for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005474. DOI: 10.1002/14651858.CD005474.

Author Information

  1. 1

    Leeds and York Partnership NHS Foundation Trust, Psychiatry, Leeds, UK

  2. 2

    Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Berlin, Germany

*Ajit Kumar, Psychiatry, Leeds and York Partnership NHS Foundation Trust, Linden House, St Mary's Hospital, Green Hill Road, Leeds, LS12 3QE, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 OCT 2005


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.